HopeStage
Back to all studies
CompletedNCT05098574

Oral contraceptives for premenstrual dysphoria in people with bipolarity

About this title

Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

Read the official source — NCT05098574
Medication studyAges 16–45Canada
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: 16 years to 45 years. Other eligibility criteria applied.

Listed locations
HamiltonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 3, 2023
Recruitment status
Completed
Enrollment listed in the registry
17
Sponsor
St. Joseph's Healthcare Hamilton
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Canada
Age range
From 16 Years to 45 Years
Official registry ID
NCT05098574
Official title
Show the full official title

A Pilot, Randomized, Placebo-Controlled Trial Evaluating the Treatment of Premenstrual Dysphoric Disorder with Oral Contraceptives in Bipolar Disorder.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Hamilton

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is St. Joseph's Healthcare Hamilton.

Did this study involve medication?

Yes. The study involved medication, including Yaz and Placebo.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 16 years to 45 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies